A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo

P.R Taylor, Anna Carugati, Valerie A Fadok, H. Terence Cook, Mark Andrews, Michael C Carroll, John Savill, Peter M Henson, Marina Botto, Mark J Walport

Research output: Contribution to journalArticlepeer-review

Abstract

The strongest susceptibility genes for the development of systemic lupus erythematosus (SLE) in humans are null mutants of classical pathway complement proteins. There is a hierarchy of disease susceptibility and severity according to the position of the missing protein in the activation pathway, with the severest disease associated with C1q deficiency. Here we demonstrate, using novel in vivo models of apoptotic cell clearance during sterile peritonitis, a similar hierarchical role for classical pathway complement proteins in vivo in the clearance of apoptotic cells by macrophages. Our results constitute the first demonstration of an impairment in the phagocytosis of apoptotic cells by macrophages in vivo in a mammalian system. Apoptotic cells are thought to be a major source of the autoantigens of SLE, and impairment of their removal by complement may explain the link between hereditary complement deficiency and the development of SLE.
Original languageEnglish
Pages (from-to)359-66
Number of pages8
JournalJournal of Experimental Medicine
Volume192
Issue number3
DOIs
Publication statusPublished - Aug 2000

Fingerprint

Dive into the research topics of 'A hierarchical role for classical pathway complement proteins in the clearance of apoptotic cells in vivo'. Together they form a unique fingerprint.

Cite this